Stock Details
ABT is Abbott Laboratories's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 112.11$. Average daily volumn in 3 months 5.51M. Market cap 190.24B



Stock symbol : ABT. Exchange : NYSE. Currency : USD
Lastest price : 108.65$. Total volume : 6.00M. Market state PRE
Click reload if you want to check the lastest price on market!!!

Abbott Laboratories (ABT)
Last Price
108.65$
Change
-0.45
Volume
6.00M

Previous Close109.10
Open108.08
Day Range107.36-109.08
Bid107.87 x 800
Ask0.00 x 1k
Volume6M
Average Volume5.51M
Market Cap190.24B
Beta0.72
52 Week Range101.24-142.60
Trailing P/E25.21
Foward P/E22.22
Dividend (Yield %)1.73%
Ex-Dividend Date2022-07-14



Financial Details


According to Abbott Laboratories's financial reports the company's revenue in 2021 were 43.08B an increase( +26.47%) over the years 2020 revenue that were of 34.61B. In 2021 the company's total earnings were 7.07B while total earnings in 2020 were 4.5B( +75%).


Loading ...



Organization

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecologi... cal disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Mรฉniรจre's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Market Cap:
190.24B
Revenue:
43.08B
Total Assets:
75.2B
Total Cash:
9.8B


News about "Abbott Laboratories"

Abbott Laboratories (ABT): Worth Noting At $107.86

Source from : stocksregister - 22 hours ago

Abbott Laboratories (NYSE:ABT) at last check was buoying at $107.86 on Thursday, June 30, with a fall of -1.14% from its closing price on previous day. Taking a look at stock we notice that its last ...See details»


INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the Firm

Source from : Lawyer Monthly - 14 hours ago

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Abbott Laboratories (โ€œAbbottโ€ or โ€œthe Companyโ€) (NYSE: ABT) for ...See details»


abbott-finds-support-around-100-image

Abbott Finds Support Around $100

Source from : Seeking Alpha - 1 days ago

Abbott seemed to bounce off of the $100 per share price on the last leg down, and that may end up being extreme support in the near term. It has been a tough year for a great many equities, including ...See details»


abbott-labs-formula-woes-spell-opportunity-for-rivals-image

Abbott Labs' formula woes spell opportunity for rivals

Source from : Crain's Chicago Business - 3 days ago

Abbott Laboratories is losing its lead in the U.S. baby formula market as the shutdown of an important manufacturing plant drags on. Contamination concerns forced the North Chicago-based company to ...See details»


what-6-analyst-ratings-have-to-say-about-abbott-laboratories-image

What 6 Analyst Ratings Have To Say About Abbott Laboratories

Source from : Business Insider - 7 days ago

Abbott Laboratories (NYSE:ABT) has observed the following analyst ratings within the last quarter: In the last 3 months, 6 analysts have offered 12-month price targets for Abbott Laboratories. The ...See details»


what-happened-at-abbott-image

What Happened at Abbott?

Source from : Heartland - 3 days ago

Listen to economists with different world views describe events and decide for yourself which view makes more sense.See details»


abbott-laboratories-nyseabt-shares-acquired-by-wealthcare-advisory-partners-llc-image

Abbott Laboratories (NYSE:ABT) Shares Acquired by Wealthcare Advisory Partners LLC

Source from : Defense World - 4 days ago

Wealthcare Advisory Partners LLC boosted its stake in Abbott Laboratories (NYSE:ABT โ€“ Get Rating) by 8.2% during the first quarter, according to its most recent 13F filing with the Securities and ...See details»


has-abbott-labs-declined-to-an-attractive-level-image

Has Abbott Labs Declined to an Attractive Level?

Source from : TheStreet.com - 7 days ago

Abbott Laboratories ( ABT) has been under selling pressure from late December before the shut down and negative publicity surrounding the baby formula shortage. Has the decline from late December to ...See details»


abbott-laboratories-nyseabt-price-target-cut-to-13000-by-analysts-at-btig-research-image

Abbott Laboratories (NYSE:ABT) Price Target Cut to $130.00 by Analysts at BTIG Research

Source from : Defense World - 6 days ago

Abbott Laboratories (NYSE:ABT โ€“ Get Rating) had its target price decreased by BTIG Research from $140.00 to $130.00 in a research note published on Friday, The Fly reports. BTIG Research currently has ...See details»


absurd-loophole-cant-keep-abbott-formula-lawsuits-in-federal-court-judge-image

'Absurd' loophole can't keep Abbott formula lawsuits in federal court -judge

Source from : Reuters - 7 days ago

Abbott Laboratories Inc cannot use a controversial legal loophole known as "snap removal" to keep lawsuits claiming that its Similac baby formula caused a deadly illness in premature infants in ...See details»


fda-investigating-another-baby-death-possibly-tied-to-abbott-formula-image

FDA investigating another baby death possibly tied to Abbott formula

Source from : New York Post - 8 days ago

The baby died in January and had โ€œconsumed an Abbott product,โ€ the Food and Drug Administration said Wednesday, citing a consumer complaint sent to the agency in February.See details»


fda-investigates-new-report-of-another-babys-death-possibly-tied-to-abbott-formula-image

FDA investigates new report of another babyโ€™s death possibly tied to Abbott formula

Source from : Fox 5 NY - 7 days ago

The FDA has reviewed dozens of complaints involving Abbott formula after the company voluntarily recalled its products in February.See details»


fda-allows-abbott-to-import-formula-from-ireland-plant-image

FDA allows Abbott to import formula from Ireland plant

Source from : Crain's Chicago Business - 2 days ago

As the nationwide formula shortage persists, officials sayย Abbottโ€™s Similac Advance formula should be available to consumers by mid-July.See details»


Here's How Much $1000 Invested In Abbott Laboratories 5 Years Ago Would Be Worth Today

Source from : Benzinga.com - 7 days ago

Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 7.3% on an annualized basis producing an average annual return of 17.14%. Currently, Abbott Laboratories has a ...See details»